January 3, 2025 - Health Technology Insights

Model N Introduces New Rebate Enhancement

January 3, 2025
HealthTech Media Room
Health, HealthTech News, Pharmaceuticals

Model N Launches Rebate Enhancement as Pharma Prepares for Inflation Act Impact

Model N, the leader in revenue optimization and compliance has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act (IRA). The company has...

OmniScience's clinical trial genAI-powered control tower

January 3, 2025
HealthTech Media Room
Clinical Trials, Health, HealthTech News

OmniScience’s Vivo Wins 1st Place at CNS Summit 2024

OmniScience was awarded top honors at the 2024 Innovation Showcase for its groundbreaking solution, Vivo – a market-first solution poised to transform clinical trial operation teams’ day-to-day workflow and...

Navigating Early-Phase Clinical Trials Key Considerations for Emerging Biotech and MedTech, Upcoming Webinar Hosted by Xtalks

January 3, 2025
HealthTech Media Room
Clinical Trials, Health, Health Services, HealthTech News

Upcoming Xtalks Webinar: Key Considerations for Early-Phase Clinical Trials

Early-phase clinical trials, including First-in-Human (FIH) studies, represent pivotal milestones for emerging biotech and MedTech companies. Success during these initial stages not only sets the foundation for US Food...

January 3, 2025
HealthTech Media Room
Clinical Trials, Health Services, Healthcare IT, HealthTech News

FreeOx’s Ox-01 to be Tested as Thrombectomy Therapy for Stroke in NINDS

FreeOx Biotech, a clinical stage biopharmaceutical company pioneering the development of a novel drug class for Acute Ischemic Stroke (AIS), announced that its lead compound, Ox-01, has been officially...

January 3, 2025
HealthTech Media Room
Cancer, Clinical Trials, Health Services, HealthTech News

Airway-On-A-Chip Could Speed Up Future Drug and Therapy Development

Developing a new drug is incredibly complex, but a new breakthrough could help scientists accelerate the process. Researchers at Draper have created a more accurate model of the human...

January 3, 2025
HealthTech Media Room
Cancer, HealthTech News

PharmaIN Unveils Phase 1b Data on PHIN-214 for Liver Cirrhosis at AASLD 2024

PharmaIN Corporation, a clinical-stage biopharmaceutical company dedicated to developing innovative subcutaneous peptide therapies, introduced interim results from its ongoing Phase 1b clinical trial of PHIN-214 for the prevention and...

January 3, 2025
HealthTech Media Room
Clinical Trials, General Healthcare Services, Health, HealthTech News

Roswell Park Study Shows Venetoclax Enhances CAR T Immune Response for CLL

A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with triple-negative breast cancer (TNBC), the most...

January 3, 2025
HealthTech Media Room
General Healthcare Services, Health, Health Services, HealthTech News

Purdue and Akston Launch Immunotherapy Trial for Dogs with Bladder Cancer

Purdue University and its College of Veterinary Medicine, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of...

January 3, 2025
HealthTech Media Room
Clinical Trials, General Healthcare Services, Health, Health Analytics, Health Services, HealthTech News

Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people...

January 3, 2025
HealthTech Media Room
Clinical Trials, Health, Health Services, HealthTech News

FDA Grants Rare Disease and Orphan Drug Status to Nobias for 22q11.2 Syndrome

Nobias Therapeutics, a clinical-stage company developing novel small-molecule therapeutics for rare diseases, announced that the United States (U.S.) Food and Drug Administration (FDA) has granted rare pediatric disease designation...

Model N Launches Rebate Enhancement as Pharma Prepares for Inflation Act Impact

OmniScience’s Vivo Wins 1st Place at CNS Summit 2024

Upcoming Xtalks Webinar: Key Considerations for Early-Phase Clinical Trials

FreeOx’s Ox-01 to be Tested as Thrombectomy Therapy for Stroke in NINDS

Airway-On-A-Chip Could Speed Up Future Drug and Therapy Development

PharmaIN Unveils Phase 1b Data on PHIN-214 for Liver Cirrhosis at AASLD 2024

Roswell Park Study Shows Venetoclax Enhances CAR T Immune Response for CLL

Purdue and Akston Launch Immunotherapy Trial for Dogs with Bladder Cancer

Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

FDA Grants Rare Disease and Orphan Drug Status to Nobias for 22q11.2 Syndrome

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands